Pune: The IPO of Emcure Pharmaceuticals Limited, supported by Namita Thapar, began on Wednesday with the aim of raising Rs 1,952.03 crore. The IPO comprises of new equity shares valued at Rs 800 crore and an offer for sale (OFS) of 1.14 crore equity shares totaling Rs 1,152 crore at the higher end of the price range, provided by promoters and current shareholders.
Emcure Pharmaceuticals disclosed on Tuesday that it secured Rs 583 crore from anchor investors. As per a circular\ posted on the BSE website, Emcure has allocated 57.8 lakh equity shares to 48 funds at a price of Rs 1,008 per share, resulting in a total transaction value of Rs 582.6 crore.
The IPO price range is from Rs 960 to Rs 1,008 per share, and will be available for public subscription between July 3 and July 5. Investors are required to bid for at least 14 shares and can increase their bid in increments of 14 shares.
ALSO READ: Govt directs utilities to procure $33 bn equipment for coal power boost
FIRST Business Portal addressing the potential of business capability of North East Region.
